データを補完しています。通常は 1 分以内に完了します
基本情報
- CAS
330796-62-8- 標準SMILES
CCCCC/C=C\C/C=C\C/C=C\C=C\[C@@H](O)CCCC(=O)O- InChIKey
KGIJOOYOSFUGPC-JGKLHWIESA-N- 分子式
- C20H32O3
- 平均分子量
- 320.5 g/mol
- 単同位体質量
- 320.23514488
名称と識別子
- 優先名称
- 5-Hydroxyeicosatetraenoic Acid
- IUPAC
- (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid
名称と別名
名称をさらに表示
データベース識別子
- CAS
330796-62-8、70608-72-9- PubChem CID
- 5280733
- DTXSID
DTXSID701017281- ChEMBL
CHEMBL164813- ChEBI
CHEBI:28209- UNII
- 467RNW8T91
- EC Number
- 633-222-7
- Nikkaji
- J390.336B
物性
構造計算による物性補完中
- XLogP
- 5.2
- 極性表面積
- 57.5 Ų
- 水素結合供与体数
- 2
- 水素結合受容体数
- 3
- 回転可能結合数
- 14
- 重原子数
- 23
- 形式電荷
- 0
- 複雑度
- 392
実験および物理化学的性質
Collision Cross Section
187.2 Ų [M-H]- [CCS Type: DT; Method: stepped-field];188.21 Ų [M+Na]+ [CCS Type: DT; Method: stepped-field]
187 Ų [M+Na]+;186.6 Ų [M-H]-
安全と法規制
GHS分類
GHS Classification
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
危険有害性情報
化学と産業
薬理情報
Metabolite Pathways
Acetaminophen Action Pathway;Acetylsalicylic Acid Action Pathway;Antipyrine Action Pathway;Antrafenine Action Pathway;Arachidonic Acid Metabolism;Bromfenac Action Pathway;Carprofen Action Pathway;Celecoxib Action Pathway;Diclofenac Action Pathway;Diflunisal Action Pathway;Total 41 pathways, visit the HMDB page for details
サプライヤー5 社
関連反応
化合物ノート
読み込み中…